Andreas Kungl

City:

Graz

Country:

Austria

Published Applications:

Last publication date:

2022-09-08

Top Assignees for applications by Andreas Kungl

The entities that hold a legal rights for patent applications filed by inventor Kungl Andreas:

PROTAFFIN BIOTECHNOLOGIE AG 6 Graz, Austria
Antagonis Biotherapeutics GmbH 2 Graz, Austria

Recent patent applications by Kungl Andreas

Andreas Kungl from Graz, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-08

US20220281934A1

Chemistry; metallurgy

T-CELL MOBILIZING CXCL10 MUTANT WITH INCREASED GLYCOSAMINOGLYCAN BINDING AFFINITY

#2 | 2018-12-27

US20180371043A1

Chemistry; metallurgy

Glycosaminoglycan-antagonising fusion proteins

#3 | 2017-03-02

US20170058012A1

Chemistry; metallurgy

Glycosaminoglycan-antagonising fusion proteins and methods of using same

#4 | 2014-03-13

US20140073557A1

Chemistry; metallurgy

FGFRI-BASED ANTAGONISTS WITH IMPROVED GLYCOSAMINOGLYCAN AFFINITY AND METHODS OF USING SAME

#5 | 2013-06-13

US20130150303A1

Chemistry; metallurgy

GLYCOSAMINOGLYCAN-ANTAGONISING MCP-1 MUTANTS AND METHODS OF USING SAME

#6 | 2012-11-15

US20120288474A1

Chemistry; metallurgy

COMPOSITION FOR TREATMENT OF CXCL8-MEDIATED LUNG INFLAMMATION

#7 | 2012-03-01

US20120052043A1

Chemistry; metallurgy

Chemokine-Chaperone Fusion Proteins

#8 | 2012-02-23

US20120046218A1

Chemistry; metallurgy

GLYCOSAMINOGLYCAN-ANTAGONISING MCP-I MUTANTS AND METHODS OF USING SAME

#9 | 2010-11-25

US20100298203A1

Chemistry; metallurgy

SDF-I-BASED GLYCOSAMINOGLYCAN ANTAGONISTS AND METHODS OF USING SAME

#10 | 2010-08-05

US20100197583A1

Chemistry; metallurgy

Glycosaminoglycan-antagonising MCP-1 mutants

InventorID:

287651 ⎘